Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 225

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 225
---
 been issued or are issuable in connection (i) the Securities Purchase Agreement dated as of June 2, 2025, (ii) a selling stockholder’s exercise of warrants to purchase 45,765 shares of common stock, and (iii) placement agent warrants issued in connection with the Offering. See “Prospectus Summary – The Private Placement” for additional information. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares for resale from time to time in accordance with the terms of the purchase and sale agreement. When we refer to “selling stockholders” in this prospectus, we mean persons listed in the table below, as well as such person’s transferees, pledgees or donees or its or their respective successors. The information regarding shares beneficially owned after the offering assumes the sale of all shares offered by the selling stockholders. The table below lists the selling stockholder and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder) of the shares of common stock held by the selling stockholders. The second column lists the number of shares of common stock beneficially owned by the selling stockholder as of September 11, 2025. The third column lists the shares of common stock being offered by this prospectus by the selling stockholders. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus. The fifth column lists the percentage of common stock owned by each selling stockholder, assuming the sale of all of the shares offered by such selling stockholder pursuant to this prospectus. In calculating the percentage of shares beneficially owned by the selling stockholders after the Offering, we have based our calculations on 51,103,535 shares of our common stock outstanding as of September 11, 2025. The selling stockholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

| Name and Address of Selling Stockholders                       |     | Number of Shares of 
 Common Stock        
 Owned Prior to      
 Offering            |         |    |     | Maximum          
 Number of        
 Shares to be     
 Sold Pursuant to 
 this Prospectus  |         |     | Number of      
 Shares of      
 Common         
 Stock Owned    
 After Offering |        |     | Percentage of 
 Common        
 Stock Owned   
 After         
 Offering(1)   |   |